Lazard Asset Management LLC Biotechnology

Lazard Asset Management LLC

$58.2 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VNDA Vanda Pharmaceuticals Inc.	$248M	$163,000 0.0% of portfolio	35,541	Q1 2025 Added 49.56%
NVAX Novavax Inc	$580M	$133,000 0.0% of portfolio	20,840	Q1 2025 Added 322.38%
MNKD Mannkind Corp	$1.11B	$112,000 0.0% of portfolio	22,305	Q1 2025 New
MIRM Mirum Pharmaceuticals, Inc.	$1.64B	$90,000 0.0% of portfolio	2,002	Q1 2025 Reduced 11.57%
FOLD Amicus Therapeutics, Inc.	$1.69B	$88,000 0.0% of portfolio	10,814	Q1 2025 Added 29.12%
GERN Geron Corp	$589M	$84,000 0.0% of portfolio	53,053	Q1 2025 Added 110.96%
MDGL Madrigal Pharmaceuticals, Inc.	$4.69B	$84,000 0.0% of portfolio	256	Q1 2025 New
ARDX Ardelyx, Inc.	$612M	$80,000 0.0% of portfolio	16,353	Q1 2025 Added 1,768.91%
ZLAB Zai Lab LTD	$3.71B	$80,000 0.0% of portfolio	2,231	Q1 2025 Reduced 94.83%
MDXG Mimedx Group, Inc.	$720M	$79,000 0.0% of portfolio	10,455	Q1 2025 Added 63.23%
AGIO Agios Pharmaceuticals, Inc.	$1.84B	$77,000 0.0% of portfolio	2,658	Q1 2025 New
APLS Apellis Pharmaceuticals, Inc.	$2.13B	$77,000 0.0% of portfolio	3,553	Q1 2025 New
KURA Kura Oncology, Inc.	$439M	$77,000 0.0% of portfolio	11,751	Q1 2025 New
IOVA Iovance Biotherapeutics, Inc.	$349M	$72,000 0.0% of portfolio	21,690	Q1 2025 Added 33,269.23%
KRYS Krystal Biotech, Inc.	$3.49B	$72,000 0.0% of portfolio	404	Q1 2025 Reduced 15.13%
SWTX Spring Works Therapeutics, Inc.	$2.92B	$69,000 0.0% of portfolio	1,579	Q1 2025 Added 1,226.89%
XERS Xeris Biopharma Holdings, Inc.	$617M	$61,000 0.0% of portfolio	11,182	Q1 2025 Reduced 94.84%
XNCR Xencor Inc	$570M	$59,000 0.0% of portfolio	5,601	Q1 2025 New
GOSS Gossamer Bio, Inc.	$118M	$48,000 0.0% of portfolio	43,761	Q1 2025 Reduced 59.28%
LGND Ligand Pharmaceuticals Inc	$1.85B	$45,000 0.0% of portfolio	435	Q1 2025 Reduced 33.99%
FHTX Foghorn Therapeutics Inc.	$172M	$35,000 0.0% of portfolio	9,808	Q1 2025 Reduced 7.31%
GLUE Monte Rosa Therapeutics, Inc.	$216M	$35,000 0.0% of portfolio	7,595	Q1 2025 New
HRTX Heron Therapeutics, Inc.	$247M	$30,000 0.0% of portfolio	13,815	Q1 2025 New
IMTX Immatics N.V.	$441M	$30,000 0.0% of portfolio	6,839	Q1 2025 Reduced 95.79%
YMAB Y M Abs Therapeutics, Inc.	$223M	$21,000 0.0% of portfolio	4,812	Q1 2025 New
MGTX Meira G Tx Holdings PLC	$256M	$14,000 0.0% of portfolio	2,109	Q1 2025 Added 2,096.88%
PBYI Puma Biotechnology, Inc.	$154M	$6,000 0.0% of portfolio	2,100	Q1 2025 Reduced 15.83%
TSVT 2seventy Bio, Inc.	$189M	$4,000 0.0% of portfolio	998	Q1 2025 Reduced 45.4%
ALEC Alector, Inc.	$116M	$2,000 0.0% of portfolio	1,752	Q1 2025 New
PLX Protalix Bio Therapeutics, Inc.	$80.1M	$2,000 0.0% of portfolio	797	Q1 2025 Reduced 36.49%
ACIU Ac Immune Sa	$155M	$1,000 0.0% of portfolio	813	Q1 2025 Added 7.4%
ADCT Adc Therapeutics Sa	$267M	$1,000 0.0% of portfolio	1,203	Q1 2025 Reduced 79.32%
MGNX Macrogenics Inc	$107M	$1,000 0.0% of portfolio	943	Q1 2025 Reduced 90.44%
SGMO Sangamo Therapeutics, Inc	$76.7M	$1,000 0.0% of portfolio	2,668	Q1 2025 Reduced 94.26%
CTMX Cytom X Therapeutics, Inc.	$171M	$0 0.0% of portfolio	816	Q1 2025 Reduced 85.18%
SILO Silo Pharma, Inc.	$1.57M	$0 0.0% of portfolio	570	Q1 2025 Reduced 40.19%
URGN Uro Gen Pharma Ltd.	$131M	$0 0.0% of portfolio	56	Q1 2025 Reduced 99.12%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.